Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ 0.07Sales per Share
VS
Market
Sector
Industry
History
$ 1.5Close
$ 0.68 - $ 3.23 52-Week Range
Ticker Information
Ticker
FATECompany Name
FATE THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQFATE THERAPEUTICS INC - Sales per Share Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
FATE - SPS Historical data
| Date | Revenues | Share Factor | Weighted Average Shares | Sales per Share |
|---|---|---|---|---|
| 6/30/2025 | $ 8.47M | 1 | 118.53M | $ 0.07 |
| 3/31/2025 | $ 13.34M | 1 | 118.38M | $ 0.11 |
| 12/31/2024 | $ 13.63M | 1 | 113.69M | $ 0.12 |
| 9/30/2024 | $ 13.45M | 1 | 117.77M | $ 0.11 |
| 6/30/2024 | $ 12.32M | 1 | 117.47M | $ 0.1 |
| 3/31/2024 | $ 6.48M | 1 | 101.1M | $ 0.06 |
| 12/31/2023 | $ 63.53M | 1 | 98.41M | $ 0.65 |
| 9/30/2023 | $ 106.21M | 1 | 98.57M | $ 1.08 |
| 6/30/2023 | $ 119.25M | 1 | 98.4M | $ 1.21 |
| 3/31/2023 | $ 136.87M | 1 | 98.05M | $ 1.4 |
Key Performance Insights, Last 5 Years
- FATE THERAPEUTICS INC's latest trailing twelve months (TTM) SPS stands at $ 0.21.
- Over the past 5 years, FATE THERAPEUTICS INC's average SPS has been $ 0.53.
- The median SPS for FATE THERAPEUTICS INC during this period was $ 0.54
- FATE THERAPEUTICS INC reached its highest SPS over the past 5 years at $ 1.4.
- The lowest SPS recorded by FATE THERAPEUTICS INC in the same timeframe $ 0.06
FATE THERAPEUTICS INC's SPS vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
SPS Benchmarks
Similar metrics to SPS:
- Book Value per Share - [Calculation] The amount of equity attributed to each share, calculated as [Equity] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Free Cash Flow per Share - [Calculation] The amount of Free Cash Flow attributed to each share, calculated as [FCF] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Operating Cash Flow per Share - [Calculation] The amount of Operating Cash Flow attributed to each share, calculated as [NCFO] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- EBIT per Share - [Calculation] The amount of earnings before interest and taxes attributed to each share, calculated as [EBIT] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- EBITDA per Share - [Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
Definition of Sales per Share
[Calculation] The amount of revenue attributed to each share, calculated as [Revenue] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].Revenues / (Shares WA * Share Factor)
(=) SPS SPS for FATE THERAPEUTICS INC is calculated as follows: Revenues [ $ 18.34M ] / (Shares WA [ 86.89M ] * Share Factor [ 1 ])
(=) SPS [ $ 0.21 ] FATE - Sales per Share, Last 5 years
$ 0.06
Minimum
Mar 31, 2024
$ 1.4
Maximum
Mar 31, 2023
$ 0.53
Average
$ 0.54
Median
SPS Benchmark AnalysisMarket
The chart above depicts the distribution of SPS for companies in the Total Stock Market. The average SPS of the companies is $ 11.55 with a standard deviation of $ 13.62.
The following table provides additional summary stats:
SPS in the Market:
| filtered constituents | 3.63K |
|---|---|
| min | $ -18.02 |
| max | $ 54.8 |
| average | $ 11.55 |
| median | $ 5.89 |
| std | $ 13.62 |